G.G. Steger

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy

Matti Aapro, Alessandra Fabi, Franco Nolè et al. · Annals of Oncology · 2010 · 147 citations

Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5

R. Jakesz, H. Hausmaninger, H. Samonigg et al. · European Journal of Cancer · 1999 · 72 citations

Breast Oncology, Medicine, Clinical Trials +11

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

Flora Zagouri, Theodoros Ν. Sergentanis, Vassilis Koutoulidis et al. · British Journal of Cancer · 2013 · 54 citations · Full text

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial

CC Zielinski, Boye Schnack, M Grbovic et al. · British Journal of Cancer · 1998 · 52 citations · Full text

Metastatic Urothelial Cancer, Urology, Phase Ii Trial +6

Fulvestrant (‘Faslodex’) in pre-treated patients with advanced breast cancer: A single-centre experience

G.G. Steger, Rupert Bartsch, C. Wenzel et al. · European Journal of Cancer · 2005 · 43 citations

Advanced Breast Cancer, Breast Oncology, Medicine +7